CLINICAL RELEVANCE OF BASELINE/EARLY DETECTION AND PERSISTENCE OF RESISTANT ASSOCIATED VARIANTS IN HCV-1 PATIENTS TREATED WITH PROTEASE-INHIBITORS ASSESSED BY ULTRA-DEEP SEQUENCING

Di Maio, Vc; Armenia, D; Bellocchi, Mc; Di Paolo, D; Cento, V; Tontodonati, M; Micheli, V; Carioti, L; De Leonardis, F; Aragri, M; Polilli, E; Manunta, A; Magni, C; Antonucci, Fp; De Luca, F; Sarrecchia, C; Bertoli, A; Lenci, I; Francioso, S; Santoro, Mm; Vecchiet, J; De Maria, A; Picciotto, A; Nosotti, L; Morisco, F; Bruno, S; Puoti, M; Babudieri, S; Mura, Ms; Taliani, G; Andreoni, M; Rizzardini, G; Parruti, G; Angelico, M; Perno, Cf; Ceccherini-Silberstein, F